QUINT Brings Concentrated Exosome Technology Home With Monthly Skin and Scalp Protocols
QUINT, the direct-to-consumer beauty biotechnology brand, has introduced Q.FACE and Q.SCALP—structured monthly microneedling protocols that combine 25 billion exosomes with precision microneedling applicators. The systems are designed to simplify at-home skincare and scalp treatments by offering standardized dosing, guided application, and a three-month protocol, positioning exosomes as an intentional treatment rather than a daily cosmetic ingredient.